Literature DB >> 19653696

Acid elution and one-dimensional shotgun analysis on an Orbitrap mass spectrometer: an application to drug affinity chromatography.

Nora V Fernbach1, Melanie Planyavsky, André Müller, Florian P Breitwieser, Jacques Colinge, Uwe Rix, Keiryn L Bennett.   

Abstract

In this study, the target profile of the promiscuous kinase inhibitor bosutinib from whole cell K562 lysates was investigated by an improved chemical proteomic approach to identify natural binders. By (i) miniaturizing the drug pulldown method, (ii) introducing a 50 microm inner diameter (i.d.) analytical column for peptide separation, (iii) decreasing the inlet flow rate to 100 nL/minute, and (iv) analyzing the samples on an LTQ Orbitrap XL mass spectrometer, it was clearly demonstrated that the entire approach could be successfully down-scaled by a factor of 100, that is, equivalent to 2 x 10(6) K562 cells. The known major targets of bosutinib were still unequivocally identified in addition to 30 targets not previously identified by gel-based mass spectrometry in our laboratory. In total, 70 individual targets were identified by mass spectrometry across this study of which 19 had not been previously reported. The down-scaled technique was made feasible by eluting the proteins that interact with bosutinib with acid and analyzing the proteins by one-dimensional shotgun proteomics. Overall, these improvements should allow utilization of very limited amounts of patient material to generate a comprehensive and comparative profile of protein drug targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653696     DOI: 10.1021/pr900455x

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  14 in total

1.  Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.

Authors:  Rui Martins; Julia Maier; Anna-Dorothea Gorki; Kilian V M Huber; Omar Sharif; Philipp Starkl; Simona Saluzzo; Federica Quattrone; Riem Gawish; Karin Lakovits; Michael C Aichinger; Branka Radic-Sarikas; Charles-Hugues Lardeau; Anastasiya Hladik; Ana Korosec; Markus Brown; Kari Vaahtomeri; Michelle Duggan; Dontscho Kerjaschki; Harald Esterbauer; Jacques Colinge; Stephanie C Eisenbarth; Thomas Decker; Keiryn L Bennett; Stefan Kubicek; Michael Sixt; Giulio Superti-Furga; Sylvia Knapp
Journal:  Nat Immunol       Date:  2016-10-31       Impact factor: 25.606

2.  A miniaturized chemical proteomic approach for target profiling of clinical kinase inhibitors in tumor biopsies.

Authors:  Ivo Chamrád; Uwe Rix; Alexey Stukalov; Manuela Gridling; Katja Parapatics; André C Müller; Soner Altiok; Jacques Colinge; Giulio Superti-Furga; Eric B Haura; Keiryn L Bennett
Journal:  J Proteome Res       Date:  2013-08-20       Impact factor: 4.466

3.  CCancer: a bird's eye view on gene lists reported in cancer-related studies.

Authors:  Sabine Dietmann; Wanseon Lee; Philip Wong; Igor Rodchenkov; Alexey V Antonov
Journal:  Nucleic Acids Res       Date:  2010-06-06       Impact factor: 16.971

4.  Characterization of the Phosphoproteome in SLE Patients.

Authors:  Xinzhou Zhang; Hualin Ma; Jianrong Huang; Yong Dai
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

5.  Using iTRAQ combined with tandem affinity purification to enhance low-abundance proteins associated with somatically mutated EGFR core complexes in lung cancer.

Authors:  Eric B Haura; André Müller; Florian P Breitwieser; Jiannong Li; Florian Grebien; Jacques Colinge; Keiryn L Bennett
Journal:  J Proteome Res       Date:  2010-11-09       Impact factor: 4.466

6.  Chemical proteomic analysis of 6-benzylaminopurine molecular partners in wheat grains.

Authors:  Radim Simerský; Ivo Chamrád; Jindřich Kania; Miroslav Strnad; Marek Šebela; René Lenobel
Journal:  Plant Cell Rep       Date:  2017-07-07       Impact factor: 4.570

7.  Identification of kinase inhibitor targets in the lung cancer microenvironment by chemical and phosphoproteomics.

Authors:  Manuela Gridling; Scott B Ficarro; Florian P Breitwieser; Lanxi Song; Katja Parapatics; Jacques Colinge; Eric B Haura; Jarrod A Marto; Giulio Superti-Furga; Keiryn L Bennett; Uwe Rix
Journal:  Mol Cancer Ther       Date:  2014-09-04       Impact factor: 6.261

8.  Optimisation of Downscaled Tandem Affinity Purifications to Identify Core Protein Complexes.

Authors:  Eric B Haura; Roberto Sacco; Jiannong Li; André C Müller; Florian Grebien; Giulio Superti-Furga; Keiryn L Bennett
Journal:  J Integr OMICS       Date:  2012-05

9.  A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib.

Authors:  Thomas R Burkard; Uwe Rix; Florian P Breitwieser; Giulio Superti-Furga; Jacques Colinge
Journal:  PLoS Comput Biol       Date:  2010-11-18       Impact factor: 4.475

10.  Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth.

Authors:  B Peter; G E Winter; K Blatt; K L Bennett; G Stefanzl; U Rix; G Eisenwort; E Hadzijusufovic; M Gridling; C Dutreix; G Hoermann; J Schwaab; D Radia; J Roesel; P W Manley; A Reiter; G Superti-Furga; P Valent
Journal:  Leukemia       Date:  2015-09-09       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.